March 4, 2021

Increased serum QUIN/KYNA is a reliable biomarker of post-stroke cognitive decline

Strokes are becoming less severe due to increased numbers of intensive care units and improved treatments. As patients survive longer, post-stroke cognitive impairment (PSCI) has become a major health public i…

 Most Recent Articles: Molecular Neurodegeneration

 Read More

Leave a Reply

%d bloggers like this: